New Report Just Published: World Multiple Myeloma Therapeutics Market Report

...Drugs: An Evaluation of Pros and Cons II-7 revlimid Overtakes Thalomid: Why? II-7 How Effective Wi...rd Line Setting? Skepticism Overflows II-7 revlimid Impedes Stem Cell Harvesting!!: What's the Truth? ...-37 Celgene Obtains Health Canada Approval for revlimid Oral Cancer Drug II-37 FDA Grants Orphan-D...

BullMarket.com Updates Outlook on Biotech Stocks

...nto a growth story in 2010? -- Why does Vertex's recent purchase of ViroChemPharma look like a smart move? -- How does Celgene's principal drug revlimid have an advantage over other multiple myeloma treatments? -- What event has been a real black eye for Genzyme? -- What recent event demonstr...

3-drug combination 'extremely promising' as first-line therapy for multiple myeloma

...known as a proteasome inhibitor that blocks the myeloma cells waste disposal system, creating an accumulation of toxic compounds that poison the cell. revlimid is a chemical relative of thalidomide that affects several pathways in cancer cells, including immune mechanisms and blood vessel growth to tumors. De...

Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting

...in Combination with Etanercept: A Phase II Study (Abstract #1452). -- Poster Board No. 612-I: Preliminary Results from a Phase I Study of revlimid (Lenalidomide) in Combination with Vidaza (Azacitidine) in Patients with Advanced Myelodysplastic Syndromes (MDS) (Abstract #1458). Date /...

Penn's Abramson Cancer Center part of major phase III study for myeloma

... a critical advance toward meeting that need." revlimid (lenalidomide) from Celgene, an oral medication wh...dhere to the wall of tissues where they will grow. revlimid may also inhibit cancer cells ability to hide from...e the effectiveness and safety of cyclic dosing of revlimid at 25mg combined with high-does dexamethasone (HDD...

Oral drug sets a new survival standard for bone marrow cancer

...s. Of those patients, 177 were assigned to receive revlimid (lenalidomide) plus dexamethasone, a steroid hormo...ording to the study results, patients who received revlimid had a median survival of 29.6 months, compared to 20.2 months for the placebo group. In the revlimid group, 61 percent of patients responded to therapy...

Drug Combo Boosts Multiple Myeloma Survival

...ients with multiple myeloma. The combination of revlimid (lenalidomide) and dexamethasone was given U.S. Fo...rically has been a difficult disease to treat. revlimid is a derivative of thalidomide, with alterations i...were randomized to receive either 25 milligrams of revlimid or a placebo for the first three weeks. Both group...

New Clinical Trial Results Could Improve Survival for Myeloma Patients

...im findings from a large ongoing clinical trial of revlimid plus dexamethasone in newly diagnosed patients, su.... "Improved survival with low dose 'dex' and revlimid is an important finding because it further improve...ry analysis of the ECOG data shows patients taking revlimid plus low dose dexamethasone had a 96% survival rat...

Revlimid Approved By FDA For Multiple Myeloma

...d Drug Administration has approved the anemia drug revlimid (lenalidomide) as a treatment for multiple myeloma..., which makes this drug will now be able to market revlimid for use in multiple myeloma. The treatment regimen...ults of clinical trials in which patients who took revlimid and dexamethasone survived an average of 29.6 mont...

Lenalidomide, Granted Approval by FDA to Join Multiple Myeloma Drugs

... and Pharmacovigilance said that FDA’s approval of revlimid (lenalidomide) offered a new oral drug option// to...pplication (sNDA) for an additional indication for revlimid (lenalidomide), for use in combination with dexame...loma who have received at least one prior therapy. revlimid is also approved for use in the treatment of patie...

Revlimid in Medical Technology

Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent

Moffitt Research Presented at 9th International Symposium on Myelodysplastic Syndromes TAMPA, Fla., May 17, 2007 /PRNewswire/ -- New updated results from a pivotal Phase II trial evaluating Revlimid in patients with an incurable blood cancer known as myelodysplastic syndromes (MDS) were presented ...

ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma

...bination with lenalidomide to treat the disease. revlimid (lenalidomide) is approved by the U.S. Food and Dr...loma who have received at least one prior therapy. revlimid is also approved for the treatment of patients wit...h or without additional cytogenetic abnormalities. revlimid recently received a positive opinion from the Euro...

The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients

...s of Dexamethasone, the Steroid Commonly Used with revlimid and other Drugs in Newly Diagnosed Myeloma - NORT...g. "Improved survival with low dose 'dex' and revlimid is an important finding because it further improve...uations, less may be more when treating cancer." revlimid from the Celgene Corporation is the newest of the ...

The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients

...nter Trial in 4 Weeks Reinforces Benefits of Using revlimid with Low Dose Steroids in Myeloma- NORTH HOLLYWOO...all patients in the study be moved to a regimen of revlimid with low- dose dexamethasone, which demons...ts trial of high dose dexamethasone versus revlimid plus high dose dexamethasone to an early c...

The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients

...ts were alive. -- And combining VELCADE plus revlimid (with a steroid) showed a response rate of...ious treatment, the 35 month median survival using revlimid in combination with dexamethasone has been charact...Phase III trial evaluating more than 400 patients, revlimid with low dose dexamethasone demonstrated what has ...

The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece

...Myeloma Platform (EMP) says updated data for previously treated patients on revlimid (lenalidomide) plus the steroid dexamethasone shows median survival of 35 m...rts here are saying that nearly three years of median over all survival for revlimid patients is the longest they have seen in myeloma to-date from large clinic...

Revlimid in Biological News

Leukemia Drug Breakthrough Study In New England Journal Of Medicine

...ducted a phase I/II trial of the experimental drug revlimid showing promise as an innovative way to treat pati...(MDS), a form of pre-leukemia. Given in pill form, revlimid simultaneously blocks the growth of new blood vess... initially developed the phase I clinical trial of revlimid for treatment of MDS following his laboratory obse...

Revlimid in Biological Technology

Biotech Hall of Fame Inductees Announced

...ssion of cutaneous manifestations of erythema nodosum leprosum, an inflammatory complication of leprosy. The company's products also include revlimid for the treatment of patients with transfusion-dependent anemia. Current market cap is $28 billion. Idexx Pharmaceuticals A leader i...